https://www.avicedarx.com/
Aviceda Therapeutics
Aviceda is the world leader in glyco-immune checkpoint therapeutics. We are developing novel, immune-mediated therapies to improve the lives of patients,...
avicedatherapeutics
https://www.businesswire.com/news/home/20231012725572/en/Aviceda-Announces-AVD-104-a-Novel-Glycomimetic-Nanoparticle-Demonstrates-Continued-Clinical-Safety-in-the-Treatment-of-Geographic-Atrophy-Secondary-to-Macular-Degeneration
Aviceda Announces AVD-104, a Novel Glycomimetic Nanoparticle, Demonstrates Continued Clinical...
Aviceda Therapeutics, a privately held, late-stage clinical biotech company focused on developing next-generation immunomodulators by harnessing the power of...
a novelavicedaannouncesavd
https://www.businesswire.com/news/home/20221108005246/en/Aviceda-Announces-Additional-World-Class-Members-to-its-Clinical-Advisory-Board-to-Support-its-Clinical-Development-Strategy-in-Ophthalmology
Aviceda Announces Additional World-Class Members to its Clinical Advisory Board to Support its...
Aviceda Therapeutics, a clinical-stage biotech company focused on developing the next generation of immuno-modulators by harnessing the power of glycobiology...
clinical advisory boardworld class
https://www.businesswire.com/news/home/20230320005017/en/Aviceda-Announces-Successful-Submission-of-an-Investigational-New-Drug-IND-and-Fast-Track-Designation-FTD-Application-for-AVD-104-for-the-Treatment-of-Geographic-Atrophy-Associated-with-Age-Related-Macular-Degeneration-AMD
Aviceda Announces Successful Submission of an Investigational New Drug (IND) and Fast Track...
Aviceda Therapeutics, a private biotech company focused on developing the next generation immuno-modulators by harnessing the power of glycobiology to modula...
investigational new drug
https://www.businesswire.com/news/home/20250401356648/en/Aviceda-Therapeutics-Appoints-Industry-Veteran-Dr.-Jeffrey-Nau-as-Chief-Executive-Officer-to-Lead-Next-Phase-of-Growth-and-Innovation
Aviceda Therapeutics Appoints Industry Veteran Dr. Jeffrey Nau as Chief Executive Officer to Lead...
Aviceda Therapeutics Appoints Industry Veteran Dr. Jeffrey Nau as Chief Executive Officer to Lead Next Phase of Growth and Innovation